NCT02521376 - Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 16, 2015

Primary Completion Date

October 25, 2017

Study Completion Date

October 25, 2017

Conditions

Oncology

Interventions

DRUG

Entospletinib

Entospletinib 100 mg tablet administered orally

Trial Locations (6)

Clinical Pharmacology of Miami, Inc. (CPMI), Miami

Orlando Clinical Research Center, Orlando

DaVita Clinical Research, Minneapolis

The Texas Liver Institute, San Antonio

APEX GmBH, Munich

Auckland Clinical Studies, Auckland